|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Reconciliation of net loss to net cash used in operating activities: | |||||
| Depreciation | |||||
| Stock-based compensation | |||||
| Amortization of premiums on investment securities, net | |||||
| Non-cash lease expense | |||||
| Deferred financing costs | |||||
| Change in operating assets and liabilities: | |||||
| Prepaid expense and other assets | |||||
| Accounts payable and other liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of investment securities | |||||
| Proceeds from maturities of investment securities | |||||
| Purchases of property and equipment | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from the issuance of common stock in at-the-market offering, net of issuance costs | |||||
| Proceeds from the exercise of stock options | |||||
| Issuance of common stock through employee stock purchase plan | |||||
| Net cash provided by financing activities | |||||
| Net decrease in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosures | |||||
| Issuance costs included in accrued expenses | |||||
Loading...